JPMorgan Chase & Co. Lowers Colgate-Palmolive (NYSE:CL) Price Target to $95.00

Colgate-Palmolive (NYSE:CL - Get Free Report) had its price objective reduced by research analysts at JPMorgan Chase & Co. from $99.00 to $95.00 in a research report issued on Friday,Benzinga reports. The firm presently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s target price indicates a potential upside of 0.73% from the stock's current price.

A number of other research analysts also recently weighed in on CL. Raymond James reiterated an "outperform" rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Friday, April 4th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. Wells Fargo & Company lifted their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research note on Wednesday, April 2nd. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $101.67.

Remove Ads

Colgate-Palmolive Price Performance

Shares of CL traded down $0.67 during midday trading on Friday, reaching $94.31. The stock had a trading volume of 3,874,781 shares, compared to its average volume of 4,575,827. The firm's 50 day moving average price is $90.65 and its 200-day moving average price is $92.51. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a market capitalization of $76.49 billion, a P/E ratio of 26.79, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business posted $0.87 earnings per share. On average, analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its Board of Directors has authorized a stock repurchase plan on Thursday, March 20th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's leadership believes its shares are undervalued.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CL. Simon Quick Advisors LLC increased its position in shares of Colgate-Palmolive by 57.2% during the first quarter. Simon Quick Advisors LLC now owns 11,117 shares of the company's stock valued at $1,042,000 after purchasing an additional 4,045 shares during the period. Zhang Financial LLC boosted its stake in Colgate-Palmolive by 56.4% in the 1st quarter. Zhang Financial LLC now owns 15,695 shares of the company's stock valued at $1,471,000 after buying an additional 5,660 shares in the last quarter. Coerente Capital Management boosted its stake in Colgate-Palmolive by 0.3% in the 1st quarter. Coerente Capital Management now owns 252,322 shares of the company's stock valued at $23,643,000 after buying an additional 723 shares in the last quarter. Trinity Financial Advisors LLC bought a new stake in Colgate-Palmolive in the first quarter valued at $639,000. Finally, CX Institutional lifted its holdings in shares of Colgate-Palmolive by 1,206.1% during the first quarter. CX Institutional now owns 59,286 shares of the company's stock valued at $5,555,000 after acquiring an additional 54,747 shares during the period. Institutional investors own 80.41% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.